Core H - The purpose of the Protein Expression and Proteomics Analysis (PEP) Core is to provide state-of- the-art technology, equipment and expertise for the cloning, expression and purification of recombinant proteins required by the San Diego (SD) CFAR community, as well as the tools and expertise required for molecular analysis of proteins and protein mixtures. In particular, the PEP Core will provide protein expression and analytical tools not available to most laboratories and at a reduced cost affordable for CFAR members. The PEP Core is divided into two units based on services provided: The Protein Expression Unit (Co-Director, John Elder) will aid CFAR members as needed for cloning, expression and/or purification of proteins, based on the needs of the investigator. This unit will also maintain stocks of frequently requested viral and immunological proteins such as HIV gp120 and Gag antigens and will aid in the purification of antibodies, as required. The Proteomics Unit (Co-Director, Bruce Torbett) maintains state-of-the-art equipment and capabilities for protein analysis including nanospray mass spectrometer, HPLC, Typhoon 3-color laser for analysis of protein mixtures, light cycler instrumentation for analyzing protein mixtures, and equipment for 1- and 2-dimensional protein separations. These technologies and provided expertise will aid investigators in quantitative and qualitative analysis of their proteins and protein mixtures from cell samples. In addition, the PEP Core will provide training to CFAR members in all facets of protein expression and analysis offered by the Core, as requested by the community. Information will be provided by both one-on-one interactions, as well as through seminars on various techniques, based on the interests of the members. The long-term goal of the Core is to help facilitate efficient and economical analysis of proteins required by the CFAR membership to aid in the more rapid development of an understanding of the HIV life cycle and the development of intervention strategies against the global spread of HIV.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI036214-24
Application #
9537794
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
24
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Naticchia, Matthew R; Laubach, Logan K; Tota, Ember M et al. (2018) Embryonic Stem Cell Engineering with a Glycomimetic FGF2/BMP4 Co-Receptor Drives Mesodermal Differentiation in a Three-Dimensional Culture. ACS Chem Biol 13:2880-2887
Blumenthal, Jill; Jain, Sonia; Mulvihill, Evan et al. (2018) Perceived versus calculated HIV risk: Implications for Pre-exposure prophylaxis uptake in a randomized trial of men who have sex with men. J Acquir Immune Defic Syndr :
Kardava, Lela; Sohn, Haewon; Youn, Christine et al. (2018) IgG3 regulates tissue-like memory B cells in HIV-infected individuals. Nat Immunol 19:1001-1012
Wagner, Karla D; Syvertsen, Jennifer L; Verdugo, Silvia R et al. (2018) A mixed methods study of the social support networks of female sex workers and their primary noncommercial male partners in Tijuana, Mexico. J Mix Methods Res 12:437-457
Bastos, Francisco I; Bastos, Leonardo Soares; Coutinho, Carolina et al. (2018) HIV, HCV, HBV, and syphilis among transgender women from Brazil: Assessing different methods to adjust infection rates of a hard-to-reach, sparse population. Medicine (Baltimore) 97:S16-S24
Cepeda, Javier A; Eritsyan, Ksenia; Vickerman, Peter et al. (2018) Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study. Lancet HIV 5:e578-e587
Namazi, Golnaz; Fajnzylber, Jesse M; Aga, Evgenia et al. (2018) The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis 218:1954-1963
Lada, Steven M; Huang, Karissa; VanBelzen, D Jake et al. (2018) Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR. J Clin Microbiol 56:
Huang, Mia L; Michalak, Austen L; Fisher, Christopher J et al. (2018) Small Molecule Antagonist of Cell Surface Glycosaminoglycans Restricts Mouse Embryonic Stem Cells in a Pluripotent State. Stem Cells 36:45-54
Skaathun, Britt; Voisin, Dexter R; Cornwell, Benjamin et al. (2018) A Longitudinal Examination of Factors Associated with Network Bridging Among YMSM: Implications for HIV Prevention. AIDS Behav :

Showing the most recent 10 out of 921 publications